A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes
Authors
Keywords
Anti-PEG IgM, PEGylated products, ABC phenomenon, Doxil®, Animal models
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 615, Issue -, Pages 121539
Publisher
Elsevier BV
Online
2022-02-03
DOI
10.1016/j.ijpharm.2022.121539
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
- (2020) Gergely Tibor Kozma et al. ADVANCED DRUG DELIVERY REVIEWS
- Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism
- (2020) Nehal E. Elsadek et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment
- (2019) Alanod D. AlQahtani et al. BIOMEDICINE & PHARMACOTHERAPY
- Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review
- (2019) Kouichi Shiraishi et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes
- (2018) Taro Shimizu et al. JOURNAL OF IMMUNOLOGY
- Novel advances in targeted drug delivery
- (2017) Kıvılcım Öztürk-Atar et al. JOURNAL OF DRUG TARGETING
- Impact of anti-PEG IgM antibodies on the pharmacokinetics of pegylated asparaginase preparations in mice
- (2016) Sabine M. Poppenborg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial
- (2014) Nicola Longo et al. LANCET
- Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs
- (2014) Yosuke Hashimoto et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
- (2014) Michael S Hershfield et al. ARTHRITIS RESEARCH & THERAPY
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Innate B cell helpers reveal novel types of antibody responses
- (2013) Carola G Vinuesa et al. NATURE IMMUNOLOGY
- Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
- (2013) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peginesatide in Patients with Anemia Undergoing Hemodialysis
- (2013) Steven Fishbane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Chemistry for peptide and protein PEGylation
- (2012) M.J. Roberts et al. ADVANCED DRUG DELIVERY REVIEWS
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA
- (2011) Tatsuaki Tagami et al. JOURNAL OF CONTROLLED RELEASE
- 307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON
- (2010) H. Tillmann et al. JOURNAL OF HEPATOLOGY
- Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
- (2008) Jong-Ho Kim et al. JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now